Last updated on July 2019

This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.


Brief description of study

The primary objective is to investigate safety and tolerability of BI 1015550 in patients with IPF.

The secondary objectives are to investigate the effect of BI 1015550 on the target engagement biomarker and to evaluate the pharmacokinetics (PK) of BI 1015550 in patients with IPF.

Clinical Study Identifier: NCT03422068

Find a site near you

Start Over

Hospital de Bellvitge

L'Hospitalet de Llobregat, Spain
  Connect »

Southampton General Hospital

Southampton, United Kingdom
  Connect »

Fraunhofer ITEM

Hannover, Germany
  Connect »

Hospital Son Espases

Palma de Mallorca, Spain
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.